First Trust Advisors’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.56M Buy
139,311
+64,023
+85% +$1.51M ﹤0.01% 1752
2026
Q1
$1.13M Sell
75,288
-59
-0.1% -$1.01K ﹤0.01% 2122
2025
Q4
$1.1M Sell
75,347
-219,749
-74% -$3.83M ﹤0.01% 2106
2025
Q3
$5.29M Sell
295,096
-148,565
-33% -$2.18M ﹤0.01% 1353
2025
Q2
$7.57M Buy
443,661
+283,090
+176% +$2.83M 0.01% 1176
2025
Q1
$1.16M Sell
160,571
-42,465
-21% -$483K ﹤0.01% 1995
2024
Q4
$2.85M Buy
203,036
+50,331
+33% +$744K ﹤0.01% 1655
2024
Q3
$1.81M Buy
152,705
+66,132
+76% +$685K ﹤0.01% 1811
2024
Q2
$805K Buy
+86,573
New +$442K ﹤0.01% 2013

Other funds holding CORZ

First Trust Advisors's CORZ Position: Q2 2026 in Review

First Trust Advisors increased its Core Scientific (CORZ) stake by 85% in Q2 2026, buying an estimated $1.51M and bringing the position to 139,311 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1752.

First Trust Advisors first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.57M in Q2 2025. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • First Trust Advisors held 139,311 shares of Core Scientific worth $3.56M as of Q2 2026.
  • First Trust Advisors bought 64,023 Core Scientific shares in Q2 2026, an estimated $1.51M.
  • Core Scientific made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1752 holding.
  • First Trust Advisors first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
  • First Trust Advisors's Core Scientific position peaked at $7.57M in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.